MedWellAI, Inc.

MedWellAI, Inc. is a Nevada-based holding company that has shifted from its earlier digital-asset/mining focus into AI-enabled healthcare and wellness businesses. Through subsidiaries such as MedWell USA and MedWell Facilities, it sells pharmaceutical products, supports provider ordering workflows, and pursues wellness-related real estate and service opportunities.

−472,2 %

−606,5 %

−89,9 %

0.14

0.14

— MedWellAI, Inc.
%
Pharmaceutical product sales85% Bulk sale and distribution of GLP medications for weight loss and diabetes management.
Commission and service revenue5% Commissions and service fees tied to customer transactions and consultation-enabled offerings.
Online sales1% Legacy online sales activity that management has said it is no longer pursuing due to regulatory hurdles.
Rental income4% Lease and sub-lease income from properties used in the wellness and healthcare ecosystem.
Holding company and investment activities5% Corporate-level acquisition, investment, and development activities that support new business lines.

The company sells primarily to healthcare-related business customers rather than consumers, especially doctors’...

  • Healthcare provider officesprimary

    Doctors' offices and similar practices buy GLP medications and related services for patient use and recurring supply needs.

  • Wellness clinics and med spasprimary

    These customers use the platform to source products and streamline ordering for weight-loss and wellness programs.

  • Corporate wellness facilitiessecondary

    Corporate wellness operators buy products and services to support employee wellness offerings.

  • Affiliated medical groups and providerssecondary

    Licensed providers deliver consultations that enable the company’s service revenue and prescription-related workflow.

MedWellAI is headquartered in the United States and its disclosed operations are centered in Nevada and Florida through...

  • Headquartered in the United States and incorporated in Nevada
  • Subsidiaries formed in Nevada to support new healthcare and wellness lines
  • Acquired Healthy Lifestyle USA LLC, a Florida-based business
  • Operations appear concentrated in the U.S. market
  • U.S. regulatory exposure is central to product and online sales strategy

Management is repositioning the company around AI-driven healthcare and wellness after earlier digital-asset activities...

01
Build the MedWell healthcare platformshort-term

The company needs a scalable operating base beyond legacy holdings and digital-asset activities.

02
Expand provider-facing distribution relationshipsmedium-term

Revenue depends on repeat purchasing from clinics and offices that need reliable supply and support.

03
Develop wellness facilities and real estatemedium-term

Facilities can create a broader ecosystem around healthcare customers and diversify revenue streams.

04
Avoid regulatory-heavy online sales modelsshort-term

Management has already said it is no longer pursuing the online sales business due to regulatory hurdles.

The company remains early-stage, loss-making, and dependent on external financing, so execution risk is high...

critical

Going concern / financing risk

The company has a history of losses and states it may need additional capital to continue operations.

Scope
Liquidity and solvency
Materiality
high
high

Customer concentration

One customer generated about 96% of revenue, so the loss of that customer would materially reduce sales.

Scope
Revenue concentration
Materiality
high
high

Regulatory risk in healthcare and online sales

Management discontinued online sales due to regulatory hurdles, showing the business model is sensitive to compliance constraints.

Scope
Product distribution and sales channels
Materiality
high
high

Key-person dependence

The CEO is the sole officer and director, so loss of that person would impair management continuity.

Scope
Leadership and execution
Materiality
high
medium

AI and technology risk

AI tools in healthcare can create privacy, bias, cybersecurity, and regulatory issues that may disrupt operations.

Scope
Platform and workflow tools
Materiality
medium
Revenue recognition under ASC 606
Can shift revenue between periods and affect reported margins
Deferred revenue
Affects working capital and near-term revenue timing
Goodwill impairment
Can create large non-cash charges and reduce equity
Lease accounting
Affects revenue timing and asset/liability presentation
Stock-based compensation
Can materially affect operating expenses and dilution

: 28/04/2026